The global D-dimer testing market is expected to reach US$ 1.8 billion by 2028 according to a new study by Report Ocean. The report “D-dimer Testing Market By Product (Analyzers, Reagents & Consumables); By Testing Method [Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Others]; By Application; By End-Use; By Regions; Global opportunity analysis and industry forecast 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global D-dimer testing industry is anticipated to grow, owing to the advent of automated PoC analyzers, patient’s awareness coupled with new pathology and labs bringing down the cost of tests and more research into the synthesis of innovative aptamers. Market players are more focused on decreasing the test’s turnaround time with the highest efficacy rates.

The global market for D-dimer testing is fragmented based on the product, method, application, end-use, and region. In terms of product, the market for D-dimer testing industry is segmented into analyzers, and reagents & consumables. The method segment is further divided into enzyme-linked immunosorbent assay (ELISA), latex-enhanced immuno-turbidimetric assays, fluorescence immunoassays, and others.

The application segment of D-dimer testing industry is further divided into deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), and others. The end-use market segment is further divided into hospitals, academic & research institutes, diagnostic centers, and others.

Segment Highlights

• The reagents & consumables market segment accounted for the largest revenue share of the global D-dimer testing industry in 2020 owing to the availability of readymade aptamers. The segment held over 60% of the global share in 2020.
• Based on method, the ELISA market segment is projected to constitute almost half of the market in 2028. The segment holds the major share due to the introduction of automated ELISA systems in the D-dimer testing industry.
• North America D-dimer testing industry accounted for the largest market revenue share in 2020. The rising cases of pulmonary embolism and deep vein thrombosis coupled with advanced clinical infrastructure boosting the usage of the concerned procedure.
• Asia Pacific D-dimer testing industry is expected register higher market growth trajectory over the study period owing to the advancements in clinical research and assay systems installations particularly in the newly established government-funded hospitals.

List of Key Players

• Diazyme Laboratories, Inc.
• Siemens Healthineers
• Thermo Fisher Scientific Inc.
• Roche Ltd.
• Abbott
• Quidel Corporation
• bioMerieux SA
• HORIBA, Ltd.
• Biomedica Diagnostics
• Sekisui Diagnostics
• Others

 D-dimer Testing, Testing Method Outlook (Revenue – USD Million, 2016 – 2028)

• Enzyme-linked Immunosorbent Assay (ELISA)
• Fluorescence Immunoassays
• Latex-enhanced Immuno-turbidimetric Assays
• Others

 D-dimer Testing, Product Outlook (Revenue – USD Million, 2016 – 2028)

• Analyzers
• Reagents & Consumables

D-dimer Testing, Application Outlook (Revenue – USD Million, 2016 – 2028)

• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Disseminated Intravascular Coagulation (DIC)
• Others

D-dimer Testing, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

• Academic & Research Institutes
• Diagnostic Centers
• Hospitals
• Others

D-dimer Testing, Regional Outlook (Revenue – USD Million, 2016 – 2028)

• North America
  • U.S.
  • Canada
• Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
• Central & South America
  • Mexico
  • Brazil
  • Argentina
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa